A significant decrease was also observed in the percentage of MHCII+, CD80+, CD86+, and CD40+ DCs in the LY294002-treated mice compared with that in the LPS-induced ALI mice (Figures 4A,B). The gene discussed is CD80; the disease is acute respiratory distress syndrome.